HRH3 and myeloid sarcoma: Here, findings from a high-throughput quantitative primary OPC screening assay, which were further supported by results of characterization of H3R expression and function in oligodendroglial lineage and gene manipulation, suggest that H3R may be a potential therapeutic target for promotion of remyelination in MS.